Erythropoietin signaling regulates heme biosynthesis
- Harvard Medical School, United States
- University of East Anglia, United Kingdom
- Kyushu University Hospital, Japan
- University of Georgia, United States
- University of Utah School of Medicine, United States
- Genome Center of Wisconsin, United States
- University of Wisconsin-Madison, United States
- Massachusetts Institute of Technology, United States
Abstract
Heme is required for survival of all cells, and in most eukaryotes, is produced through a series of eight enzymatic reactions. Although heme production is critical for many cellular processes, how it is coupled to cellular differentiation is unknown. Here, using zebrafish, murine, and human models, we show that erythropoietin (EPO) signaling, together with the GATA1 transcriptional target, AKAP10, regulates heme biosynthesis during erythropoiesis at the outer mitochondrial membrane. This integrated pathway culminates with the direct phosphorylation of the crucial heme biosynthetic enzyme, ferrochelatase (FECH) by protein kinase A (PKA). Biochemical, pharmacological, and genetic inhibition of this signaling pathway result in a block in hemoglobin production and concomitant intracellular accumulation of protoporphyrin intermediates. Broadly, our results implicate aberrant PKA signaling in the pathogenesis of hematologic diseases. We propose a unifying model in which the erythroid transcriptional program works in concert with post-translational mechanisms to regulate heme metabolism during normal development.
Article and author information
Author details
Johannes Gottfried Wittig
David J Pagliarini
Funding
National Heart, Lung, and Blood Institute (P01 HL032262)
- Barry H Paw
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK096501)
- Harry A Dailey
American Society of Hematology
- Daniel E Bauer
National Heart, Lung, and Blood Institute (P01 HL032262)
- Harvey F Lodish
- Daniel E Bauer
- Stuart H Orkin
- Alan B Cantor
National Institutes of Health (R01 GM115591)
- David J Pagliarini
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK098672)
- David J Pagliarini
National Institutes of Health (P41 GM108538)
- Joshua J Coon
National Institute of Diabetes and Digestive and Kidney Diseases (U54 DK110858)
- John D Phillips
Diamond Blackfan Anemia Foundation
- Barry H Paw
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK070838)
- Barry H Paw
American Cancer Society (RSG-13-379-01-LIB)
- Takahiro Maeda
American Society of Hematology
- Jacky Chung
Canadian Institutes of Health Research
- Jacky Chung
National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK093705)
- Daniel E Bauer
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK052380)
- Jerry Kaplan
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK090257)
- John D Phillips
National Institutes of Health (R01 GM114122)
- Joshua J Coon
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: In full compliance with BWH IACUC A4752-01 (Protocol #2016N000117) and BCH IACUC Protocol #15-07-2974R.
Copyright
© 2017, Chung et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,481
- views
-
- 518
- downloads
-
- 36
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Erythropoietin signaling regulates heme biosynthesis
eLife 6:e24767.
https://doi.org/10.7554/eLife.24767
Further reading
-
- Chromosomes and Gene Expression
- Developmental Biology
Most teleost fishes exhibit a biphasic life history with a larval oceanic phase that is transformed into morphologically and physiologically different demersal, benthic, or pelagic juveniles. This process of transformation is characterized by a myriad of hormone-induced changes, during the often abrupt transition between larval and juvenile phases called metamorphosis. Thyroid hormones (TH) are known to be instrumental in triggering and coordinating this transformation but other hormonal systems such as corticoids, might be also involved as it is the case in amphibians. In order to investigate the potential involvement of these two hormonal pathways in marine fish post-embryonic development, we used the Malabar grouper (Epinephelus malabaricus) as a model system. We assembled a chromosome-scale genome sequence and conducted a transcriptomic analysis of nine larval developmental stages. We studied the expression patterns of genes involved in TH and corticoid pathways, as well as four biological processes known to be regulated by TH in other teleost species: ossification, pigmentation, visual perception, and metabolism. Surprisingly, we observed an activation of many of the same pathways involved in metamorphosis also at an early stage of the larval development, suggesting an additional implication of these pathways in the formation of early larval features. Overall, our data brings new evidence to the controversial interplay between corticoids and thyroid hormones during metamorphosis as well as, surprisingly, during the early larval development. Further experiments will be needed to investigate the precise role of both pathways during these two distinct periods and whether an early activation of both corticoid and TH pathways occurs in other teleost species.
-
- Developmental Biology
- Neuroscience
Adolescence is characterized by changes in reward-related behaviors, social behaviors, and decision-making. These behavioral changes are necessary for the transition into adulthood, but they also increase vulnerability to the development of a range of psychiatric disorders. Major reorganization of the dopamine system during adolescence is thought to underlie, in part, the associated behavioral changes and increased vulnerability. Here, we utilized fast scan cyclic voltammetry and microdialysis to examine differences in dopamine release as well as mechanisms that underlie differential dopamine signaling in the nucleus accumbens (NAc) core of adolescent (P28-35) and adult (P70-90) male rats. We show baseline differences between adult and adolescent-stimulated dopamine release in male rats, as well as opposite effects of the α6 nicotinic acetylcholine receptor (nAChR) on modulating dopamine release. The α6-selective blocker, α-conotoxin, increased dopamine release in early adolescent rats, but decreased dopamine release in rats beginning in middle adolescence and extending through adulthood. Strikingly, blockade of GABAA and GABAB receptors revealed that this α6-mediated increase in adolescent dopamine release requires NAc GABA signaling to occur. We confirm the role of α6 nAChRs and GABA in mediating this effect in vivo using microdialysis. Results herein suggest a multisynaptic mechanism potentially unique to the period of development that includes early adolescence, involving acetylcholine acting at α6-containing nAChRs to drive inhibitory GABA tone on dopamine release.
